<?xml version="1.0" encoding="UTF-8"?>
<p id="para110">In pre-clinical experiments,
 <xref rid="bib10" ref-type="bibr">
  <sup>10</sup>
 </xref> GLS-5300, a DNA vaccine expressing a full-length MERS coronavirus S-glycoprotein antigen was broadly immunogenic in mice, camels, and non-human primates. GLS-5300 protected non-human primates from radiological and histopathological evidence of pneumonia following MERS coronavirus challenge.
 <xref rid="bib11" ref-type="bibr">
  <sup>11</sup>
 </xref> We therefore did a phase 1 study to assess the safety and immunogenicity of GLS-5300 in humans.
</p>
